You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Denosumab for the prevention of osteoporotic fractures in postmenopausal women

  • Technology appraisal guidance
  • Reference number: TA204
  • Published:  27 October 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA204 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix A - provisional matrix of stakeholders

TA204 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix A - provisional matrix of stakeholders TA204 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix A - provisional matrix of stakeholders
27 August 2013
(102.12 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 23 August 2013

Back to top